Literature DB >> 16757171

Current insights into the formation and breakdown of hemidesmosomes.

Sandy H M Litjens1, José M de Pereda, Arnoud Sonnenberg.   

Abstract

Hemidesmosomes are multiprotein adhesion complexes that promote epithelial stromal attachment in stratified and complex epithelia. Modulation of their function is of crucial importance in a variety of biological processes, such as differentiation and migration of keratinocytes during wound healing and carcinoma invasion, in which cells become detached from the substrate and acquire a motile phenotype. Although much is known about the signaling potential of the alpha6beta4 integrin in carcinoma cells, the events that coordinate the disassembly of hemidesmosomes during differentiation and wound healing remain unclear. The binding of alpha6beta4 to plectin has a central role in hemidesmosome assembly and it is becoming clear that disrupting this interaction is a crucial event in hemidesmosome disassembly. In addition, further insight into the functional interplay between alpha3beta1 and alpha6beta4 has contributed to our understanding of hemidesmosome disassembly and cell migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757171     DOI: 10.1016/j.tcb.2006.05.004

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  114 in total

1.  α6β4 integrin, a master regulator of expression of integrins in human keratinocytes.

Authors:  Kristina R Kligys; Yvonne Wu; Susan B Hopkinson; Surinder Kaur; Leonidas C Platanias; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

2.  Integrin: Basement membrane adhesion by corneal epithelial and endothelial cells.

Authors:  Tina B McKay; Ursula Schlötzer-Schrehardt; Sonali Pal-Ghosh; Mary Ann Stepp
Journal:  Exp Eye Res       Date:  2020-07-23       Impact factor: 3.467

3.  BPAG1-e restricts keratinocyte migration through control of adhesion stability.

Authors:  Magdalene Michael; Rumena Begum; Kenneth Fong; Celine Pourreyrone; Andrew P South; John A McGrath; Maddy Parsons
Journal:  J Invest Dermatol       Date:  2013-09-11       Impact factor: 8.551

4.  The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome.

Authors:  Peter T Yu; Michele Babicky; Dawn Jaquish; Randy French; Karly Marayuma; Evangeline Mose; Sherry Niessen; Heather Hoover; David Shields; David Cheresh; Benjamin F Cravatt; Andrew M Lowy
Journal:  Int J Cancer       Date:  2012-03-08       Impact factor: 7.396

5.  Keratins Stabilize Hemidesmosomes through Regulation of β4-Integrin Turnover.

Authors:  Kristin Seltmann; Fang Cheng; Gerhard Wiche; John E Eriksson; Thomas M Magin
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

6.  The structure of the plakin domain of plectin reveals a non-canonical SH3 domain interacting with its fourth spectrin repeat.

Authors:  Esther Ortega; Rubén M Buey; Arnoud Sonnenberg; José M de Pereda
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

7.  EGF-induced MAPK signaling inhibits hemidesmosome formation through phosphorylation of the integrin {beta}4.

Authors:  Evelyne Frijns; Norman Sachs; Maaike Kreft; Kevin Wilhelmsen; Arnoud Sonnenberg
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

8.  Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling.

Authors:  Viktor Todorović; Bhushan V Desai; Melanie J Schroeder Patterson; Evangeline V Amargo; Adi D Dubash; Taofei Yin; Jonathan C R Jones; Kathleen J Green
Journal:  J Cell Sci       Date:  2010-09-28       Impact factor: 5.285

Review 9.  Diseases of epidermal keratins and their linker proteins.

Authors:  Jouni Uitto; Gabriele Richard; John A McGrath
Journal:  Exp Cell Res       Date:  2007-04-24       Impact factor: 3.905

Review 10.  Integrins in Wound Healing.

Authors:  Leeni Koivisto; Jyrki Heino; Lari Häkkinen; Hannu Larjava
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-12-01       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.